Increased IL-2 secretion directly upregulates MHC-I expression, enhances immune cell infiltration and T cell activation, increases the immunogenicity of PTC cells, and overcomes immune evasion, thereby limiting tumor progression. This evidence concerns the gene IL2 and neoplasm.